FR0004163111

GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to…

2 weeks ago

GENFIT Announces Appointment of new Chief Medical Officer

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to…

6 months ago